Accerelated formulation development for inhaled therapies
We're rethinking how inhaled drugs are formulated. At Microsol, we combine precise single-particle measurements with predictive simulations to design better formulations, faster. That means earlier decisions, less material, and fewer failures. It’s a smarter, de-risked path to delivering complex therapies, especially biologics, into the lungs where they need to work.
Read more